Cervix Cancer
115
25
34
51
Key Insights
Highlights
Success Rate
85% trial completion
Research Maturity
51 completed trials (44% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
7.8%
9 terminated out of 115 trials
85.0%
-1.6% vs benchmark
6%
7 trials in Phase 3/4
18%
9 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 51 completed trials
Clinical Trials (115)
Hyaluronic Acid-based Gel Spacers in Gynecologic Malignancies
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV
Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery
Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya
Uniting Trusted Community Messengers to Improve Access to Cervical Cancer Screening in Rural North Carolina
Phase II Study of AK104 (Cadonilimab) for Recurrent Small Cell Neuroendocrine Carcinomas of the Cervix
Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers
Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries
Matrix Metalloproteinases and Human Papillomavirus in Dysplasias and Cancers of the Cervix
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV
A Study of Pembrolizumab And Platinum With Radiotherapy in Cervix Cancer
Postoperative Hypofractionated Whole Pelvic Radiotherapy in Cervical and Endometrial Cancer
Survival Monitoring in Russian Cancer Registries
Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)
Cervix Hypoxia FAZA
AssociatiNG Bevacizumab bEmarituzumab for GynecoLogIcal CAncer